Ayta, Danneza Mae P.
HRN: 27-64-59 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2025
AMPICILLIN 1GM (VIAL)
08/18/2025
08/19/2025
IVTT
2g
Q6h
PROM
Checking Initial Appropriateness
08/18/2025
CO-AMOXICLAV 625MG (TAB)
08/18/2025
08/25/2025
ORAL
625mg
BID
S/P NSD With Repair; PROM
Checking Initial Appropriateness